Connective Tissue Massage And Classical Massage In Patients With Chronic Non-Specific Low Back Pain.

NCT06135142 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-03

No results posted yet for this study

Summary

Objective This study aimed to compare the effects of connective tissue massage and classical massage on pain, functional status and quality of life in patients with chronic non-specific low back pain.

Methods The study included 30 participants diagnosed with chronic non-specific low back pain. Participants were randomly divided into three groups: classical massage (n=10), connective tissue massage (n=10), and control groups (n=10). The control group received standart physical therapy only. All interventions were administered over a period of 3 days per week for 4 weeks, with each session lasting approximately 15-20 minutes. All assessments were performed at baseline and at the end of 4 weeks. For all participants, the severity of pain was assessed using the Visual Analog Scale, the level of impaired function was measured using the Functional Low Back Pain Scale, lumbar mobility was evaluated with the Modified Schober Test and Sit and Reach Test, physical disabilities were gauged using the Roland Morris Disability Questionnaire, and the quality of life was assessed using the Short Form-36 Quality of Life questionnaire.

Conditions

  • Low Back Pain

Interventions

OTHER

Connective Tissue Massage

It involves manipulating the soft and deep tissues of the body.

DEVICE

Transcutaneous Electrical Nerve Stimulation (TENS)

The sum of therapeutic modalities of physical medicine capable to change the threshold of elicitation of nerve or muscle.

OTHER

Classical Massage

It involves manipulating the soft tissues of the body.

DEVICE

Therapatic Ultrasound

The sum of therapeutic modalities of physical medicine capable to change the threshold of elicitation of nerve or muscle.

OTHER

Heat Treatment

Applying heat to an affected area to treat damaged muscles, joints or tissues in the body.

Sponsors & Collaborators

  • Cansu DAL

    lead OTHER

Principal Investigators

  • Cansu DAL · Muğla Sıtkı Koçman University

  • Meltem KOÇ · Muğla Sıtkı Koçman University

  • Banu BAYAR · Muğla Sıtkı Koçman University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-16
Primary Completion
2024-05-08
Completion
2024-12-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06135142 on ClinicalTrials.gov